European Healthcare Expenditure on Pharmaceuticals and Medical Non-Durable Goods by Retailers of Medical Goods by Country

In 2023, Germany led European healthcare expenditure on pharmaceuticals and medical non-durable goods with 825.85 EUR per capita, showing a 4.82% year-on-year growth. Iceland and Ireland followed with 674.69 EUR and 602.17 EUR, registering 3.49% and 1.87% increases, respectively. Notable growth included Cyprus at 14.71% and Malta at 8.48%. Countries like Norway and Italy saw slight declines. Central and Eastern European countries had lower expenditures, such as Poland with 194.72 EUR and Bosnia and Herzegovina at 108.91 EUR. The overall trend reflects cautious growth, with some variability across the region.

Future trends to monitor include:

• Market shifts as countries adapt to demographic changes and aging populations.
• Impact of digital health initiatives and innovations in drug delivery systems.
• Potential cost-saving measures driven by economic fluctuations and healthcare reforms.